Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
|2||Active, not recruiting||
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
† Study has passed its completion date and status has not been verified in more than two years.